PROFILE 3D® 680R38Recalls & reported problems
Medtronic, Inc. · RING 680R38 PROFILE 3D 26L MEXICO · Class 2 · Implant
- Adverse event reports
- 9
- Deaths reported
- 0
- Injuries reported
- 9
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 9 adverse event reports that list this exact device (DI 00613994759191), received between Jan 14, 2021 and Feb 16, 2026 — classified as 9 injuries.
The most frequently reported specific device problem is “Patient Device Interaction Problem” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Patient Device Interaction Problem4
- Adverse Event Without Identified Device or Use Problem2
- Insufficient Device Problem Information2
- Intravalvular regurgitation1
Patient problems
- Heart Block3
- Insufficient Information3
- Mitral Valve Insufficiency/ Regurgitation1
- Non specific EKG/ECG Changes1
- Pericardial Effusion1
Recent adverse event reports
The 9 most recent of 9 reports, in the reporter's own words as published by the FDA.
InjuryFeb 16, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT 9 YEARS POST IMPLANT OF THIS 38MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN DEVICE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 24344977 ↗InjuryMar 18, 2025Insufficient Device Problem Information; Insufficient Device Problem Information
IT WAS REPORTED THAT POST IMPLANT OF THIS 38MM PROFILE 3D MITRAL RING, IT WAS EXPLANTED AND REPLACED WITH A 33MM MOSAIC MITRAL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 21630279 ↗InjuryNov 14, 2024Intravalvular regurgitation; Intravalvular regurgitation
MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE REPLACEMENT DEVICE WAS A NON-MEDTRONIC PRODUCT. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Mitral Valve Insufficiency/ Regurgitation
MAUDE report 20681066 ↗InjuryOct 1, 2024Patient Device Interaction Problem; Patient Device Interaction Problem
MEDTRONIC RECEIVED INFORMATION THAT 3 DAYS POST IMPLANT OF THIS 38MM MITRAL ANNULOPLASTY RING, A PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR THE PERMANENT PACEMAKER WAS REPORTED AS THIRD-DEGREE ATRIOVENTRICULAR BLOCK. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Heart Block
MAUDE report 20345332 ↗InjurySep 26, 2024Patient Device Interaction Problem; Patient Device Interaction Problem
MEDTRONIC RECEIVED INFORMATION THAT 7 YEARS AND 2 MONTHS POST IMPLANT OF THIS 38MM MITRAL ANNULOPLASTY RING, A REPLACEMENT PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR THE PERMANENT PACEMAKER WAS REPORTED AS COMPLETE HEART BLOCK (CHB). NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Heart Block
MAUDE report 20308835 ↗InjuryMay 23, 2024Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 5 YEARS POST IMPLANT OF THIS 38MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN PRODUCT. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 19382665 ↗InjuryDec 27, 2023Patient Device Interaction Problem; Patient Device Interaction Problem
MEDTRONIC RECEIVED ADDITIONAL INFORMATION WHICH STATED THAT THE EVENT IS POSSIBLY RELATED TO THE DEVICE DUE TO SURGICAL INTERVENTION ON THE HEART CAVITIES. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Pericardial Effusion
MAUDE report 18397021 ↗InjuryDec 27, 2023Patient Device Interaction Problem; Patient Device Interaction Problem
MEDTRONIC RECEIVED ADDITIONAL INFORMATION WHICH INDICATED THAT THE PACEMAKER WAS IMPLANTED 13 DAYS POST IMPLANT OF THE 38MM MITRAL A NNULOPLASTY RING. IT WAS STATED THAT IT IS POSSIBLE THAT PERIOPERATIVE DAMAGE OF THE CONDUCTION SYSTEM OCCURRED DUE TO THE REPLACEMENT PROCEDURE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Heart Block
MAUDE report 18396993 ↗InjuryJan 14, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
MEDTRONIC RECEIVED INFORMATION THAT 7 DAYS POST IMPLANT OF THIS 38MM MITRAL ANNULOPLASTY RING, A PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR THE PERMANENT PACEMAKER IMPLANT WAS REPORTED AS SICK SINUS SYNDROME . NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Non specific EKG/ECG Changes
MAUDE report 11171265 ↗
Other RING, ANNULOPLASTY devices
- CG FUTURE™ 638BL32Medtronic, Inc. · RING, ANNULOPLASTY1 death71 reports
- PROFILE 3D® 680R28Medtronic, Inc. · RING, ANNULOPLASTY1 death67 reports
- CG FUTURE™ 638BL30Medtronic, Inc. · RING, ANNULOPLASTY1 death65 reports
- CG FUTURE™ 638RL32Medtronic, Inc. · RING, ANNULOPLASTY59 reports
- Tri-Ad™ 900SFC228Medtronic, Inc. · RING, ANNULOPLASTY4 deaths56 reports
- CG FUTURE™ 638BL34Medtronic, Inc. · RING, ANNULOPLASTY51 reports
- Contour 3D® 690R30Medtronic, Inc. · RING, ANNULOPLASTY1 death50 reports
- CG FUTURE™ 638RL30Medtronic, Inc. · RING, ANNULOPLASTY1 death47 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.